Frankfurt - Delayed Quote EUR
Ultragenyx Pharmaceutical Inc. (UP0.F)
33.40
+1.20
+(3.73%)
At close: June 13 at 8:00:54 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.27M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FUST MATTHEW K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| WELCH DANIEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| DUNSIRE DEBORAH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| NARACHI MICHAEL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| SULIMAN SHEHNAAZ Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| SANDERS CORAZON CORSEE D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| RAY AMRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2025 |
| CROMBEZ ERIC M.D. Officer | Sale at price 35.11 - 39.24 per share. | Direct | 28,901 | May 5, 2025 |
| HORN HOWARD Chief Financial Officer | Sale at price 40.40 per share. | Direct | 72,114 | Mar 6, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 42.10 - 42.48 per share. | Indirect | 4,153,571 | Mar 3, 2025 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Sale at price 42.10 per share. | Direct | 253,779 | Mar 3, 2025 |
| HUIZENGA THEODORE ALAN Officer | Sale at price 42.10 per share. | Direct | 40,711 | Mar 3, 2025 |
| PINION JOHN RICHARD Officer | Sale at price 42.10 per share. | Direct | 607,882 | Mar 3, 2025 |
| CROMBEZ ERIC M.D. Officer | Sale at price 42.10 per share. | Direct | 376,584 | Mar 3, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 42.10 per share. | Direct | 540,817 | Mar 3, 2025 |
| HARRIS ERIK Officer | Sale at price 42.10 per share. | Direct | 635,836 | Mar 3, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HUIZENGA THEODORE ALAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HUANG DENNIS KARL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PINION JOHN RICHARD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| CROMBEZ ERIC M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HARRIS ERIK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HORN HOWARD Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 42.75 - 42.93 per share. | Direct | 128,224 | Feb 27, 2025 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 42.23 per share. | Indirect | 495,231 | Dec 30, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 50.00 per share. | Indirect | 413,650 | Dec 10, 2024 |
| HUIZENGA THEODORE ALAN Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 10, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 9, 2024 |
| HORN HOWARD Chief Financial Officer | Sale at price 52.76 per share. | Direct | 393,853 | Oct 10, 2024 |
| HUIZENGA THEODORE ALAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 55.85 per share. | Indirect | 1,117,000 | Sep 3, 2024 |
| HUIZENGA THEODORE ALAN Officer | Sale at price 56.19 per share. | Direct | 5,113 | Sep 3, 2024 |
| KAKKIS EMIL D Chief Executive Officer | Sale at price 50.17 per share. | Indirect | 1,003,400 | Aug 6, 2024 |
| SANDERS CORAZON CORSEE D Director | Sale at price 40.98 per share. | Direct | 23,932 | Jul 2, 2024 |
| FUST MATTHEW K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| WELCH DANIEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| DUNSIRE DEBORAH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| NARACHI MICHAEL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| SULIMAN SHEHNAAZ Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| SANDERS CORAZON CORSEE D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| RAY AMRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 18, 2024 |
| PARSCHAUER KARAH HERDMAN Officer | Sale at price 45.00 per share. | Direct | 441,270 | Jun 12, 2024 |
| SANDERS CORAZON CORSEE D Director | Sale at price 41.10 per share. | Direct | 71,391 | Jun 10, 2024 |
| CROMBEZ ERIC M.D. Officer | Sale at price 43.66 per share. | Direct | 15,456 | May 2, 2024 |
| CROMBEZ ERIC M.D. Officer | Sale at price 44.10 per share. | Direct | 6,262 | Apr 18, 2024 |
| KASSBERG THOMAS RICHARD Chairman of the Board | Sale at price 49.93 per share. | Direct | 574,644 | Mar 11, 2024 |
| FUST MATTHEW K. Director | Sale at price 50.85 - 50.89 per share. | Direct | 620,443 | Mar 7, 2024 |
Related Tickers
GXEA.F Galapagos NV
24.60
+0.82%
GLPG.VI Galapagos NV
24.92
+0.81%
38I.F Intellia Therapeutics, Inc.
6.79
-9.44%
4DN.MU Denali Therapeutics Inc.
12.91
-2.23%
2L9.F Blueprint Medicines Corporation
109.00
-0.91%
26CA.F ImmunityBio, Inc.
2.6460
-3.18%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
VNDA Vanda Pharmaceuticals Inc.
4.5100
-2.59%
MRUS Merus N.V.
54.61
-1.41%
GOVX GeoVax Labs, Inc.
1.0300
-9.65%